1. Home
  2. IBIO vs UTSI Comparison

IBIO vs UTSI Comparison

Compare IBIO & UTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IBIO
  • UTSI
  • Stock Information
  • Founded
  • IBIO 2008
  • UTSI 1991
  • Country
  • IBIO United States
  • UTSI China
  • Employees
  • IBIO N/A
  • UTSI N/A
  • Industry
  • IBIO Biotechnology: Pharmaceutical Preparations
  • UTSI Telecommunications Equipment
  • Sector
  • IBIO Health Care
  • UTSI Telecommunications
  • Exchange
  • IBIO Nasdaq
  • UTSI Nasdaq
  • Market Cap
  • IBIO 24.3M
  • UTSI 25.9M
  • IPO Year
  • IBIO N/A
  • UTSI 2000
  • Fundamental
  • Price
  • IBIO $3.80
  • UTSI $2.45
  • Analyst Decision
  • IBIO Strong Buy
  • UTSI
  • Analyst Count
  • IBIO 3
  • UTSI 0
  • Target Price
  • IBIO $4.87
  • UTSI N/A
  • AVG Volume (30 Days)
  • IBIO 427.1K
  • UTSI 1.6K
  • Earning Date
  • IBIO 05-12-2025
  • UTSI 04-11-2025
  • Dividend Yield
  • IBIO N/A
  • UTSI N/A
  • EPS Growth
  • IBIO N/A
  • UTSI N/A
  • EPS
  • IBIO N/A
  • UTSI N/A
  • Revenue
  • IBIO $375,000.00
  • UTSI $10,878,000.00
  • Revenue This Year
  • IBIO $36.00
  • UTSI N/A
  • Revenue Next Year
  • IBIO $33.33
  • UTSI N/A
  • P/E Ratio
  • IBIO N/A
  • UTSI N/A
  • Revenue Growth
  • IBIO 650.00
  • UTSI N/A
  • 52 Week Low
  • IBIO $1.50
  • UTSI $2.20
  • 52 Week High
  • IBIO $6.89
  • UTSI $3.22
  • Technical
  • Relative Strength Index (RSI)
  • IBIO 38.87
  • UTSI 50.47
  • Support Level
  • IBIO $3.80
  • UTSI $2.31
  • Resistance Level
  • IBIO $4.23
  • UTSI $2.50
  • Average True Range (ATR)
  • IBIO 0.44
  • UTSI 0.03
  • MACD
  • IBIO -0.15
  • UTSI 0.01
  • Stochastic Oscillator
  • IBIO 6.21
  • UTSI 75.00

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp operates as a telecom infrastructure provider. It develops technology for bandwidth from cloud-based services, mobile, streaming, and other applications. The range of solutions is designed to expand and modernize telecommunications networks through smooth network system integration, lower operating costs, and increased broadband access. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. The company operates in China, India, Japan, Taiwan and other countries.

Share on Social Networks: